ONCOL REP 润色咨询

ONCOLOGY REPORTS

出版年份:1994 年文章数:5979 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:5.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=814735, encodeId=5e03814e3579, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:33:32 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893683, encodeId=a827893683f7, content=我9/2号投稿的,到现在还是under review,问编辑说的也不清楚,一般多久审稿能回来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Thu Oct 22 09:24:45 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897764, encodeId=124689e764ec, content=10.24 投稿<br>10.26 under review<br>11.6 Transfer Offered to Molecular and Clinical Oncology<br>吐血!没有什么理由,就是建议转投。晕倒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=79d68463, createdName=jianlnm, createdTime=Sun Nov 08 17:52:12 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895729, encodeId=12e4895e292f, content=有医院踢出这个刊的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Fri Oct 30 21:18:46 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589629, encodeId=35d6589629f9, content=大家别投这个,去年11月投稿,目前一审意见还没回,接近半年杳无音讯,感觉还可能被拒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/19/0ecf852417cb79dc5461c5f5efeea7ef.jpg, createdBy=ffc01716697, createdName=Dr.YYY, createdTime=Fri Apr 24 00:00:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803629, encodeId=e0e38036294d, content=今年4月投稿了文章,昨天修回,让补实验。但邮件里说修回是通过邮件回复他修改后的文稿和图片,而不是通过线上的投稿系统。这正常吗?有人最近遇到类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Tue Jul 21 08:14:36 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893990, encodeId=0093893990ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志真的太慢了,前后6个多月了,反复修改多次,被拒了。建议在意投稿速度的慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Fri Oct 23 19:11:32 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-08-28 ms9405311671463132

    我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=814735, encodeId=5e03814e3579, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:33:32 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893683, encodeId=a827893683f7, content=我9/2号投稿的,到现在还是under review,问编辑说的也不清楚,一般多久审稿能回来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Thu Oct 22 09:24:45 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897764, encodeId=124689e764ec, content=10.24 投稿<br>10.26 under review<br>11.6 Transfer Offered to Molecular and Clinical Oncology<br>吐血!没有什么理由,就是建议转投。晕倒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=79d68463, createdName=jianlnm, createdTime=Sun Nov 08 17:52:12 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895729, encodeId=12e4895e292f, content=有医院踢出这个刊的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Fri Oct 30 21:18:46 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589629, encodeId=35d6589629f9, content=大家别投这个,去年11月投稿,目前一审意见还没回,接近半年杳无音讯,感觉还可能被拒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/19/0ecf852417cb79dc5461c5f5efeea7ef.jpg, createdBy=ffc01716697, createdName=Dr.YYY, createdTime=Fri Apr 24 00:00:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803629, encodeId=e0e38036294d, content=今年4月投稿了文章,昨天修回,让补实验。但邮件里说修回是通过邮件回复他修改后的文稿和图片,而不是通过线上的投稿系统。这正常吗?有人最近遇到类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Tue Jul 21 08:14:36 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893990, encodeId=0093893990ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志真的太慢了,前后6个多月了,反复修改多次,被拒了。建议在意投稿速度的慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Fri Oct 23 19:11:32 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2021-06-28 amma229

    五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=814735, encodeId=5e03814e3579, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:33:32 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893683, encodeId=a827893683f7, content=我9/2号投稿的,到现在还是under review,问编辑说的也不清楚,一般多久审稿能回来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Thu Oct 22 09:24:45 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897764, encodeId=124689e764ec, content=10.24 投稿<br>10.26 under review<br>11.6 Transfer Offered to Molecular and Clinical Oncology<br>吐血!没有什么理由,就是建议转投。晕倒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=79d68463, createdName=jianlnm, createdTime=Sun Nov 08 17:52:12 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895729, encodeId=12e4895e292f, content=有医院踢出这个刊的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Fri Oct 30 21:18:46 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589629, encodeId=35d6589629f9, content=大家别投这个,去年11月投稿,目前一审意见还没回,接近半年杳无音讯,感觉还可能被拒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/19/0ecf852417cb79dc5461c5f5efeea7ef.jpg, createdBy=ffc01716697, createdName=Dr.YYY, createdTime=Fri Apr 24 00:00:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803629, encodeId=e0e38036294d, content=今年4月投稿了文章,昨天修回,让补实验。但邮件里说修回是通过邮件回复他修改后的文稿和图片,而不是通过线上的投稿系统。这正常吗?有人最近遇到类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Tue Jul 21 08:14:36 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893990, encodeId=0093893990ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志真的太慢了,前后6个多月了,反复修改多次,被拒了。建议在意投稿速度的慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Fri Oct 23 19:11:32 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2021-01-05 14717fcdm36(暂无昵称)

    被中科院列为中度预警的期刊,投这个还能毕业吗?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=814735, encodeId=5e03814e3579, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:33:32 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893683, encodeId=a827893683f7, content=我9/2号投稿的,到现在还是under review,问编辑说的也不清楚,一般多久审稿能回来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Thu Oct 22 09:24:45 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897764, encodeId=124689e764ec, content=10.24 投稿<br>10.26 under review<br>11.6 Transfer Offered to Molecular and Clinical Oncology<br>吐血!没有什么理由,就是建议转投。晕倒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=79d68463, createdName=jianlnm, createdTime=Sun Nov 08 17:52:12 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895729, encodeId=12e4895e292f, content=有医院踢出这个刊的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Fri Oct 30 21:18:46 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589629, encodeId=35d6589629f9, content=大家别投这个,去年11月投稿,目前一审意见还没回,接近半年杳无音讯,感觉还可能被拒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/19/0ecf852417cb79dc5461c5f5efeea7ef.jpg, createdBy=ffc01716697, createdName=Dr.YYY, createdTime=Fri Apr 24 00:00:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803629, encodeId=e0e38036294d, content=今年4月投稿了文章,昨天修回,让补实验。但邮件里说修回是通过邮件回复他修改后的文稿和图片,而不是通过线上的投稿系统。这正常吗?有人最近遇到类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Tue Jul 21 08:14:36 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893990, encodeId=0093893990ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志真的太慢了,前后6个多月了,反复修改多次,被拒了。建议在意投稿速度的慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Fri Oct 23 19:11:32 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-10-22 ms7000002114122850

    我9/2号投稿的,到现在还是under review,问编辑说的也不清楚,一般多久审稿能回来啊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=814735, encodeId=5e03814e3579, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:33:32 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893683, encodeId=a827893683f7, content=我9/2号投稿的,到现在还是under review,问编辑说的也不清楚,一般多久审稿能回来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Thu Oct 22 09:24:45 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897764, encodeId=124689e764ec, content=10.24 投稿<br>10.26 under review<br>11.6 Transfer Offered to Molecular and Clinical Oncology<br>吐血!没有什么理由,就是建议转投。晕倒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=79d68463, createdName=jianlnm, createdTime=Sun Nov 08 17:52:12 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895729, encodeId=12e4895e292f, content=有医院踢出这个刊的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Fri Oct 30 21:18:46 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589629, encodeId=35d6589629f9, content=大家别投这个,去年11月投稿,目前一审意见还没回,接近半年杳无音讯,感觉还可能被拒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/19/0ecf852417cb79dc5461c5f5efeea7ef.jpg, createdBy=ffc01716697, createdName=Dr.YYY, createdTime=Fri Apr 24 00:00:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803629, encodeId=e0e38036294d, content=今年4月投稿了文章,昨天修回,让补实验。但邮件里说修回是通过邮件回复他修改后的文稿和图片,而不是通过线上的投稿系统。这正常吗?有人最近遇到类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Tue Jul 21 08:14:36 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893990, encodeId=0093893990ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志真的太慢了,前后6个多月了,反复修改多次,被拒了。建议在意投稿速度的慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Fri Oct 23 19:11:32 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-11-08 jianlnm

    10.24 投稿
    10.26 under review
    11.6 Transfer Offered to Molecular and Clinical Oncology
    吐血!没有什么理由,就是建议转投。晕倒

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=814735, encodeId=5e03814e3579, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:33:32 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893683, encodeId=a827893683f7, content=我9/2号投稿的,到现在还是under review,问编辑说的也不清楚,一般多久审稿能回来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Thu Oct 22 09:24:45 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897764, encodeId=124689e764ec, content=10.24 投稿<br>10.26 under review<br>11.6 Transfer Offered to Molecular and Clinical Oncology<br>吐血!没有什么理由,就是建议转投。晕倒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=79d68463, createdName=jianlnm, createdTime=Sun Nov 08 17:52:12 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895729, encodeId=12e4895e292f, content=有医院踢出这个刊的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Fri Oct 30 21:18:46 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589629, encodeId=35d6589629f9, content=大家别投这个,去年11月投稿,目前一审意见还没回,接近半年杳无音讯,感觉还可能被拒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/19/0ecf852417cb79dc5461c5f5efeea7ef.jpg, createdBy=ffc01716697, createdName=Dr.YYY, createdTime=Fri Apr 24 00:00:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803629, encodeId=e0e38036294d, content=今年4月投稿了文章,昨天修回,让补实验。但邮件里说修回是通过邮件回复他修改后的文稿和图片,而不是通过线上的投稿系统。这正常吗?有人最近遇到类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Tue Jul 21 08:14:36 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893990, encodeId=0093893990ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志真的太慢了,前后6个多月了,反复修改多次,被拒了。建议在意投稿速度的慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Fri Oct 23 19:11:32 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-10-30 wh66ksbs

    有医院踢出这个刊的么

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=814735, encodeId=5e03814e3579, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:33:32 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893683, encodeId=a827893683f7, content=我9/2号投稿的,到现在还是under review,问编辑说的也不清楚,一般多久审稿能回来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Thu Oct 22 09:24:45 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897764, encodeId=124689e764ec, content=10.24 投稿<br>10.26 under review<br>11.6 Transfer Offered to Molecular and Clinical Oncology<br>吐血!没有什么理由,就是建议转投。晕倒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=79d68463, createdName=jianlnm, createdTime=Sun Nov 08 17:52:12 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895729, encodeId=12e4895e292f, content=有医院踢出这个刊的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Fri Oct 30 21:18:46 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589629, encodeId=35d6589629f9, content=大家别投这个,去年11月投稿,目前一审意见还没回,接近半年杳无音讯,感觉还可能被拒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/19/0ecf852417cb79dc5461c5f5efeea7ef.jpg, createdBy=ffc01716697, createdName=Dr.YYY, createdTime=Fri Apr 24 00:00:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803629, encodeId=e0e38036294d, content=今年4月投稿了文章,昨天修回,让补实验。但邮件里说修回是通过邮件回复他修改后的文稿和图片,而不是通过线上的投稿系统。这正常吗?有人最近遇到类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Tue Jul 21 08:14:36 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893990, encodeId=0093893990ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志真的太慢了,前后6个多月了,反复修改多次,被拒了。建议在意投稿速度的慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Fri Oct 23 19:11:32 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-04-24 Dr.YYY

    大家别投这个,去年11月投稿,目前一审意见还没回,接近半年杳无音讯,感觉还可能被拒!

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=814735, encodeId=5e03814e3579, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:33:32 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893683, encodeId=a827893683f7, content=我9/2号投稿的,到现在还是under review,问编辑说的也不清楚,一般多久审稿能回来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Thu Oct 22 09:24:45 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897764, encodeId=124689e764ec, content=10.24 投稿<br>10.26 under review<br>11.6 Transfer Offered to Molecular and Clinical Oncology<br>吐血!没有什么理由,就是建议转投。晕倒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=79d68463, createdName=jianlnm, createdTime=Sun Nov 08 17:52:12 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895729, encodeId=12e4895e292f, content=有医院踢出这个刊的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Fri Oct 30 21:18:46 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589629, encodeId=35d6589629f9, content=大家别投这个,去年11月投稿,目前一审意见还没回,接近半年杳无音讯,感觉还可能被拒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/19/0ecf852417cb79dc5461c5f5efeea7ef.jpg, createdBy=ffc01716697, createdName=Dr.YYY, createdTime=Fri Apr 24 00:00:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803629, encodeId=e0e38036294d, content=今年4月投稿了文章,昨天修回,让补实验。但邮件里说修回是通过邮件回复他修改后的文稿和图片,而不是通过线上的投稿系统。这正常吗?有人最近遇到类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Tue Jul 21 08:14:36 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893990, encodeId=0093893990ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志真的太慢了,前后6个多月了,反复修改多次,被拒了。建议在意投稿速度的慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Fri Oct 23 19:11:32 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-07-21 影像哥哥

    今年4月投稿了文章,昨天修回,让补实验。但邮件里说修回是通过邮件回复他修改后的文稿和图片,而不是通过线上的投稿系统。这正常吗?有人最近遇到类似的情况吗?

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=814735, encodeId=5e03814e3579, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:33:32 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893683, encodeId=a827893683f7, content=我9/2号投稿的,到现在还是under review,问编辑说的也不清楚,一般多久审稿能回来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Thu Oct 22 09:24:45 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897764, encodeId=124689e764ec, content=10.24 投稿<br>10.26 under review<br>11.6 Transfer Offered to Molecular and Clinical Oncology<br>吐血!没有什么理由,就是建议转投。晕倒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=79d68463, createdName=jianlnm, createdTime=Sun Nov 08 17:52:12 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895729, encodeId=12e4895e292f, content=有医院踢出这个刊的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Fri Oct 30 21:18:46 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589629, encodeId=35d6589629f9, content=大家别投这个,去年11月投稿,目前一审意见还没回,接近半年杳无音讯,感觉还可能被拒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/19/0ecf852417cb79dc5461c5f5efeea7ef.jpg, createdBy=ffc01716697, createdName=Dr.YYY, createdTime=Fri Apr 24 00:00:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803629, encodeId=e0e38036294d, content=今年4月投稿了文章,昨天修回,让补实验。但邮件里说修回是通过邮件回复他修改后的文稿和图片,而不是通过线上的投稿系统。这正常吗?有人最近遇到类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Tue Jul 21 08:14:36 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893990, encodeId=0093893990ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志真的太慢了,前后6个多月了,反复修改多次,被拒了。建议在意投稿速度的慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Fri Oct 23 19:11:32 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-10-21 14792e5am71(暂无昵称)

    想问一下各位,这个杂志submitted状态之后直接是under review吗?

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=814735, encodeId=5e03814e3579, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:33:32 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893683, encodeId=a827893683f7, content=我9/2号投稿的,到现在还是under review,问编辑说的也不清楚,一般多久审稿能回来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Thu Oct 22 09:24:45 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897764, encodeId=124689e764ec, content=10.24 投稿<br>10.26 under review<br>11.6 Transfer Offered to Molecular and Clinical Oncology<br>吐血!没有什么理由,就是建议转投。晕倒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=79d68463, createdName=jianlnm, createdTime=Sun Nov 08 17:52:12 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895729, encodeId=12e4895e292f, content=有医院踢出这个刊的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Fri Oct 30 21:18:46 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589629, encodeId=35d6589629f9, content=大家别投这个,去年11月投稿,目前一审意见还没回,接近半年杳无音讯,感觉还可能被拒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/19/0ecf852417cb79dc5461c5f5efeea7ef.jpg, createdBy=ffc01716697, createdName=Dr.YYY, createdTime=Fri Apr 24 00:00:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803629, encodeId=e0e38036294d, content=今年4月投稿了文章,昨天修回,让补实验。但邮件里说修回是通过邮件回复他修改后的文稿和图片,而不是通过线上的投稿系统。这正常吗?有人最近遇到类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Tue Jul 21 08:14:36 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893990, encodeId=0093893990ff, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志真的太慢了,前后6个多月了,反复修改多次,被拒了。建议在意投稿速度的慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Fri Oct 23 19:11:32 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-10-23 影像哥哥

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:这个杂志真的太慢了,前后6个多月了,反复修改多次,被拒了。建议在意投稿速度的慎投!

    0

共500条页码: 3/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分